Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc.
WKN: A1XCY0 / Symbol: RARE / Name: Ultragenyx / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
21,61 €
-3,53 %
Ultragenyx Pharmaceutical (RARE) had its price target raised by Wells Fargo & Company from $45.00 to $46.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
Ultragenyx Pharmaceutical (RARE) had its price target raised by Citigroup Inc. from $45.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
Ultragenyx Pharmaceutical (RARE) had its price target raised by Canaccord Genuity Group Inc. from $81.00 to $83.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
Neueste Beiträge
Canaccord_Genuity_Gr in Ultragenyx Pharmaceutical Inc. diskutieren